The article discusses the renewed interest in creating genetically modified babies through the use of CRISPR gene editing technology. The first private company to announce plans for editing human embryos is called Manhattan Project, co-founded by entrepreneur Cathy Tie. Manhattan Project aims to explore safer gene correction methods in human embryos with a focus on preventing heritable diseases. While many scientists and bioethicists still view the idea as irresponsible due to safety concerns and ethical issues, some investors are eager to push the boundaries of what is possible. Pronatalists, who fear declining birth rates, believe that gene editing could offer